Navigation Links
Neuro Intervention Market: New Strategic Landscape & Market Forecast
Date:3/7/2013

DUBLIN, March 7, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Neuro Intervention Market: New Strategic Landscape & Market Forecast" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The global neuro intervention market resumed double digit growth and is poised to surpass $1.2 billion in revenue by the end of the year.

The rollout of the much anticipated Target Tenzing family of rapid detachment embolic coils from Stryker, coupled with stellar performance from both the flow diverter and neurovascular thrombectomy devices segments contributed to overall growth.

Neurovascular Intervention Market is still undergoing consolidation with leading players acquiring innovative startups at an unprecedented rate. After Covidien's acquisition of ev3 for $2.6 billion, the company snapped Reverse Medical's line of neurovascular guide catheters.

Stryker, which became the undisputed market leader after its acquisition of Boston Scientific's neurovascular division for $1.5 billion, coughed another $130 million for Concentric Medical and announced its intentions to acquire a next generation Flow Diverter.

After acquiring Micrus Endovascular for $480 million, Codman & Shurtleff spun off its surgical instruments business to Symmetry Medical for $165m in cash in a move that would sharpen its focus on the neuro intervention space and replenish its financial war chest for targeted acquisitions.

Neuro Intervention Market Report is the latest update of Medtech Ventures best-selling strategic audit of the industry. The report analyzes revenue and growth trends for the entire sector with special emphasis on embolic coils, intracranial stents, Flow Diverters, liquid embolics and thrombectomy devices.

The report also segments the market based on disease areas with special emphasis on endovascular cerebral aneurysm repair (ECAR) and both acute and chronic cerebral ischemia.

Neuro Intervention Market Report examines Leading companies technologies, product offerings, market shares and strategic positions, uncovers areas with maturing trends as well as areas with high growth potential and provides an updated forecast to 2017.


Companies Mentioned

- Balt Extrusion
- Cardiatis
- CoAxia
- Codman Neurovascular
- Concentric Medical
- Covidien
- ev3
- Gore Medical
- ITGI Medical
- Johnson & Johnson
- Merlin MD
- MicroVention
- Micrus Endovascular
- MindFrame
- NeuroInterventions
- NeuroVasx
- Nfocus Neuromedical
- Penumbra
- Phenox GmbH
- Reverse Medical
- Sequent Medical
- Stryker
- Surpass Medical
- Terumo
- Valor Medical



For more information visit http://www.researchandmarkets.com/research/tw3x7d/neuro


Research and Markets
Laura Wood , Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +1-353-1-481-1716
Sector: Central Nervous System



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
2. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
3. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
4. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
5. Neurocrine Biosciences Reports First Quarter 2012 Results
6. Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance
7. The ALS Therapy Development Institute Partners with Neurotune to Investigate Potential Treatments for Motor Neuron Disease
8. San Diego Based Neurosurgeon Offers Groundbreaking Treatment to Restore Function for People Suffering from Mobility Inhibiting Paralysis
9. NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
10. Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)
11. Catheters (Cardiovascular, Specialty, Urological, Neurovascular, and Intravenous) Market Will Reach USD 33.3 Billion Globally in 2017: Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, ... a Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, ... winners, announced today online at www.diabetesscholars.org by ... 1 diabetes stand in the way of academic and ... the Foundation,s scholarship program since 2012, and continues to ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
Breaking Medicine News(10 mins):